文献速递神经技术与安全PETMR

探究深度学习增强的实际超低剂量淀粉样蛋白PET/MR成像是否需同步采集

Investigating Simultaneity for Deep Learning-Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging.
PubMed 文献 · AJNR Am J Neuroradiol · 2022-01-27

研究纳入48名参与者,用U-Net深度学习网络将超低剂量[18F]florbetaben PET与同步或非同步结构MRI结合生成诊断质量PET图像。结果显示两种条件下增强图像均接近标准剂量图像,三个定量指标显著改善且无同步性差异,31/32对增强图像判读相似,提示非同步MRI也可用于增强超低剂量淀粉样蛋白PET。

要点

  • 深度学习增强的超低剂量淀粉样蛋白PET图像在同步与非同步MRI条件下均接近标准剂量图像质量。
  • 三个定量指标在所有网络中均显著改善,且未因是否同步采集而出现差异。
  • 31/32对增强图像判读结果相似,支持非同步PET/CT与MRI采集的可行性。

核心结论

  • 使用增强超低剂量PET联合非同步或同步MRI均可生成准确的淀粉样蛋白PET图像,拓宽了超低剂量淀粉样蛋白PET成像的用途。

研究设计与样本

  • 研究招募48名参与者,其中32名(20名女性,平均67.7岁,SD 7.9)用于预训练,注射328(SD 32)MBq [18F]florbetaben;另16名(6名女性,平均71.4岁,SD 8.7)分两次扫描,分别注射6.5(SD 3.8)和300(SD 14)MBq [18F]florbetaben,在集成PET/MR上于注射后90-110分钟同步采集结构MRI与PET;训练多个基于U-Net的深度网络,输入超低剂量PET联合来自超低剂量 session(同步)或标准剂量PET session(非同步)的MRI。

诊断标准与关键数值

  • 定性评估显示,同步和非同步条件下增强图像均与标准剂量图像相似。
  • 三个定量指标显示所有网络均显著改善,且未因同步性出现差异。
  • 不同图像类型和网络训练方法间标准化摄取值比相关性均高,31/32对增强图像判读相似。

临床应用与阅片要点

  • 作者认为,使用增强超低剂量PET联合非同步或同步MRI均可生成准确的淀粉样蛋白PET图像,拓宽了超低剂量淀粉样蛋白PET成像的用途。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Diagnostic-quality amyloid PET images can be created with deep learning using actual ultra-low-dose PET images and simultaneous structural MR imaging. Here, we investigated whether simultaneity is required; if not, MR imaging-assisted ultra-low-dose PET imaging could be performed with separate PET/CT and MR imaging acquisitions.

MATERIALS AND METHODS: We recruited 48 participants: Thirty-two (20 women; mean, 67.7 [SD, 7.9] years) were used for pretraining; 328 (SD, 32) MBq of [18F] florbetaben was injected. Sixteen participants (6 women; mean, 71.4 [SD. 8.7] years of age) were scanned in 2 sessions, with 6.5 (SD, 3.8) and 300 (SD, 14) MBq of [18F] florbetaben injected, respectively. Structural MR imaging was acquired simultaneously with PET (90-110 minutes postinjection) on integrated PET/MR imaging in 2 sessions. Multiple U-Net-based deep networks were trained to create diagnostic PET images. For each method, training was done with the ultra-low-dose PET as input combined with MR imaging from either the ultra-low-dose session (simultaneous) or from the standard-dose PET session (nonsimultaneous). Image quality of the enhanced and ultra-low-dose PET images was evaluated using quantitative signal-processing methods, standardized uptake value ratio correlation, and clinical reads.

RESULTS: Qualitatively, the enhanced images resembled the standard-dose image for both simultaneous and nonsimultaneous conditions. Three quantitative metrics showed significant improvement for all networks and no differences due to simultaneity. Standardized uptake value ratio correlation was high across different image types and network training methods, and 31/32 enhanced image pairs were read similarly.

CONCLUSIONS: This work suggests that accurate amyloid PET images can be generated using enhanced ultra-low-dose PET and either nonsimultaneous or simultaneous MR imaging, broadening the utility of ultra-low-dose amyloid PET imaging.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Chen, Adeyeri, Toueg, et al. Investigating Simultaneity for Deep Learning-Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging. AJNR Am J Neuroradiol. 2022. PMID: 35086799. doi:10.3174/ajnr.A7410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。